Our latest paper on targeting TUT4/7 in acute myeloid leukaemia went live at 7PM, coinciding perfectly with the eclipse. A hike from work to watch and celebrate. More to follow tomorrow, thanks to everyone who contributed, @kamilkranc , @CarrollDonal and many, many others.
Delighted to share our new work in @NatureCancer in collaboration with @SchofieldOxford led by @hannahjlawson & James Holt-Martyn. We found that HIF hydroxylases are potent therapeutic targets in AML. @ICR_London. https://t.co/cb3K90Wlot. 1/4
Preprint alert!
https://t.co/P2aqRezWEG
A very enjoyable work led by @VilmaDembitz perseverance and talent but also made possible by the help provided by a wide range of excellent senior and junior collaborators. A refreshing experience for a young academic! Thread 👇 1/10
A time and single-cell resolved model of hematopoiesis: https://t.co/nl5Fup1oCI. With @kamilkranc and @CarrollDonal groups, we have generated a new model of hematopoiesis, fit for the single cell genomics era, building on @fabian_theis group https://t.co/by7kWSFs41. @SCICambridge
Please direct contact me if you are interested. Funding will be available to extend position further if needed and there are lots of interesting projects in the lab and scope for more in AML and cancer metabolism
https://t.co/6VF56K1a2p
Research technician job is available in my group at Haemato-Oncology Centre, Barts Cancer Institute. Opportunity to work in a beautiful campus in the middle of London and wonderful scientists and physicians. Promise to fulfill your desire to learn! https://t.co/iCF3X2PXne
So pleased to see our CITED2 paper out in @stemcellreports. We found that Cited2 deletion results in HSC loss via Mcl1 & Pten downregulation. Incredibly, we reveal that unperturbed hematopoiesis can be sustained long-term while the HSC pool is depleted! https://t.co/aABTqOxXGZ
Very proud to announce our latest paper @nature showing the development and characterisation of the first-in-class catalytic inhibitor of METTL3 against AML. A superb collaboration between our lab (@TheMilnerInst, @sangerinstitute), @storm_tx and @TKLABUK
https://t.co/oy5Lf5wKkd
In a paper published today in Nature, see how exciting work at the Milner Institute, in collaboration with @storm_tx , has made a promising step towards developing a new drug for treating acute myeloid leukaemia.
https://t.co/gm4StWEkVl
@TKLABUK@TzelepisLab
Thanks to my examinors @RushworthLab, @GrannemanSander and supervisors @kamilkranc, @CarrollDonal aparently i'm now a Dr! Now time for a drink and to change my passport.
Congratulations to Dr @MapperleyChris for passing his PhD viva! Many thanks to Stuart @RushworthLab and @GrannemanSander for examining Chris and @CarrollDonal for great co-supervision. Good luck with your postdoc in HSC and RNA biology @QMBCI.
Sometimes, to understand what something does you must first figure out what it doesn't do!
In the latest #preprint from our lab, we demonstrate that the peptidylarginine deiminase PADI4 is dispensible for cell-autonomous haematopoietic development
1/
https://t.co/I9dRwH1byG
The O’Carroll lab is looking for talented postdoctoral research associates to join us in our quest to explore piRNA-directed DNA methylation.
https://t.co/YptkH9tbkq